Primary Job Title EIR Primary Organization 
Biomark Capital
Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male
Investor Type
Dr. Redei is an Entrepreneur-in-Residence in the venture capital group with two decades of experience in healthcare technology, the pharmaceutical industry, and academia. He is a former University of California, San Francisco faculty member and holds an M.D., as well as a Ph.D. in Applied Neuroinformatics. He comes to Burrill & Company from
Roche/Genentech, a leader in personalized healthcare.
Before joining Burrill, he headed clinical and imaging informatics at Roche for all six therapeutic areas globally, including CNS. At Roche, he was instrumental in developing a number of group-wide emerging IT strategies and implemented the company’s first forays into on-demand/cloud computing for clinical applications, and digital health. He also led the informatics effort of a consortium of five pharma companies to enable disease understanding, incorporating biosample, imaging, and clinical data sources from around the globe.
